PT Tunas Baru Lampung (TBLA) Stock Analysis 2026: Financials, Valuation, B50 Growth and Risks for U.S. Investors
 |
| PT Tunas Baru Lampung Tbk (IDX: TBLA) |
Worldreview1989 - PT Tunas Baru Lampung Tbk (IDX: TBLA) is an Indonesian agribusiness company that may look unfamiliar to most U.S. investors, but its business sits at the intersection of several major global themes: palm oil, biodiesel, food products, sugar and emerging-market energy security.
For American investors searching for undervalued international stocks, TBLA is particularly interesting because its valuation is relatively low compared with the company's earnings and book value. However, the stock also carries a significant risk that should not be ignored: high financial leverage.
The company's 2025 results were substantially stronger than 2024. Revenue increased 31.4% to approximately Rp22.88 trillion, while net profit attributable to shareholders increased to approximately Rp900.9 billion from Rp701.0 billion. EBITDA also increased 17.4% to Rp3.70 trillion.
At the same time, interest-bearing debt increased 20.9% to approximately Rp17.90 trillion while cash and equivalents declined 46.5% to about Rp667.8 billion.
That combination creates an important investment question:
Is TBLA an undervalued Indonesian palm-oil and biodiesel company, or is its low valuation simply compensation for its high debt and commodity exposure?
For U.S. investors, that is the central issue.
TBLA at a Glance
| Metric | FY2025 / Latest Available |
|---|---|
| Stock | PT Tunas Baru Lampung Tbk |
| Indonesian ticker | TBLA |
| Primary exchange | Indonesia Stock Exchange |
| FY2025 Revenue | Rp22.88 trillion |
| FY2025 Net Income | Rp900.9 billion |
| FY2025 EBITDA | Rp3.70 trillion |
| Total Assets | Rp30.52 trillion |
| Total Liabilities | Rp21.27 trillion |
| Equity | Rp9.25 trillion |
| Interest-Bearing Debt | Rp17.90 trillion |
| Cash & Equivalents | Rp667.8 billion |
| FY2025 EPS | approximately Rp150 |
| Latest referenced share price | approximately Rp615 |
| Approx. trailing P/E | ~4.1x |
| Approx. Price-to-Book | ~0.40x |
The FY2025 financial figures are based primarily on the company's own investor materials and financial disclosures. The referenced market price of around Rp615 is based on the latest available market data around August 14, 2026.
Important: TBLA is an Indonesian-listed equity, not a U.S.-listed blue-chip stock. A U.S. investor therefore needs to consider Indonesian market access, Indonesian rupiah currency exposure, liquidity, taxation and emerging-market risk in addition to the company's operating performance.
What Does PT Tunas Baru Lampung Do?
PT Tunas Baru Lampung is part of Indonesia's agribusiness ecosystem and operates across several businesses, including palm oil, biodiesel/FAME, cooking oil and sugar.
Its integrated model gives the company exposure to both agricultural production and downstream processing.
This matters because TBLA is not simply a plantation company.
Its business model includes:
Oil-palm plantations
Crude palm oil processing
Biodiesel/FAME
Cooking oil
Sugar
Manufacturing and processing activities
Domestic and export-oriented markets
The company reported approximately 66,370 hectares of total oil-palm planted area in FY2025, including 51,367 hectares of mature plantations and 15,003 hectares of immature plantations. It also reported approximately 14,396 hectares of sugar-cane plantations.
This creates an interesting diversification effect.
A U.S. investor can think of TBLA as a combination of:
Agriculture + food processing + renewable fuel + emerging-market commodity exposure.
Why TBLA's 2025 Results Matter
The biggest improvement in TBLA's recent investment story was the acceleration of revenue and profitability during 2025.
According to the company's FY2025 investor newsletter:
Revenue rose 31.4%
Gross profit rose 26.6%
Operating profit rose 22.6%
Net profit rose 28.5%
EBITDA rose 17.4%
Revenue increased from approximately Rp17.41 trillion in 2024 to Rp22.88 trillion in 2025. Net profit increased from approximately Rp701.0 billion to Rp900.9 billion.
This is important because the growth was not merely a result of cost cutting.
The company experienced strong growth in its biodiesel-related business.
Biodiesel Is Becoming a Major TBLA Growth Driver
One of the most important developments for TBLA is Indonesia's increasing biodiesel mandate.
Indonesia moved to B40 in 2025, meaning biodiesel represented 40% of the blend in the relevant diesel program.
In 2026, the Indonesian government moved further toward B50, meaning a 50% biodiesel blend.
The Ministry of Energy and Mineral Resources announced the implementation of the B50 program in July 2026.
This is highly relevant to TBLA.
The company's FY2025 newsletter stated that FAME/biodiesel sales increased 110.4% year over year to approximately 771,000 kiloliters, with biodiesel's revenue contribution rising to 47.6%, compared with 26.3% in the previous year.
That is a dramatic change in revenue composition.
For investors, this means TBLA is increasingly connected to Indonesia's domestic energy policy rather than being solely dependent on conventional palm-oil demand.
Why B50 Could Be a Major Catalyst
Indonesia's government launched the B50 mandate as part of its strategy to reduce diesel imports and increase domestic utilization of palm-based biodiesel.
The Ministry of Energy and Mineral Resources estimates that B50 could increase domestic CPO absorption and potentially generate substantial foreign-exchange savings.
The government has also established specifications for B50 fuel containing 50% biodiesel.
For TBLA, the economic logic is straightforward:
Higher biodiesel mandates → higher FAME demand → higher CPO demand → greater utilization of processing capacity.
The company stated that it expects B50 to create additional demand for CPO and that it is preparing to utilize its approximately 1 million kiloliters-per-year production capacity.
However, investors should not assume that every increase in biodiesel volume automatically becomes an equal increase in shareholder profit.
That is because the company must also purchase substantial quantities of external CPO.
The Hidden Issue: TBLA Does Not Produce All the CPO It Needs
One of the most important details in the company's 2025 disclosure is that its internal palm-oil production was insufficient to satisfy biodiesel demand.
TBLA's CPO production increased 23.3% to approximately 315,000 tons in FY2025.
However, the company purchased approximately 672,000 tons of external CPO to meet demand from the FAME business.
This creates both an opportunity and a risk.
Opportunity
Higher biodiesel volumes can increase factory utilization and revenue.
Risk
TBLA becomes more dependent on the price and availability of externally purchased CPO.
If CPO prices rise sharply while biodiesel economics do not compensate for the increase, revenue can grow without producing equivalent growth in shareholder earnings.
This is why investors should watch gross margin and EBITDA margin, not revenue alone.
FY2025 Financial Analysis
TBLA's FY2025 numbers present a mixed but improving picture.
Revenue
Revenue:
Rp22.88 trillion
versus:
Rp17.41 trillion in 2024
Growth:
31.4%
This is a strong top-line increase.
Gross Profit
Gross profit increased from:
Rp3.00 trillion → Rp3.80 trillion
or approximately:
+26.6%
However, gross profit grew more slowly than revenue.
That pushed the gross margin down from approximately 17.2% to 16.6%.
For investors, this is an important warning sign.
The company is growing, but it is not converting every additional rupiah of revenue into proportionally higher gross profit.
Net Profit Analysis
Net income attributable to shareholders reached approximately:
Rp900.9 billion
compared with:
Rp701.0 billion in 2024
representing approximately:
28.5% growth.
The approximate net profit margin was:
Rp900.9 billion ÷ Rp22.88 trillion = 3.94%
That is relatively thin.
In other words, TBLA can generate billions of dollars-equivalent in revenue while retaining only a small percentage as net income.
This is typical of businesses with:
high raw-material costs,
significant financing costs,
commodity-price exposure,
manufacturing operations and
large working-capital requirements.
Therefore, TBLA should not be analyzed like a software company where revenue growth can translate into very high incremental margins.
EBITDA: A Better Measure of Operating Strength
FY2025 EBITDA was approximately:
Rp3.70 trillion
compared with:
Rp3.16 trillion in 2024
representing approximately 17.4% growth.
The EBITDA margin was approximately:
16.2%
based on the company's reported FY2025 EBITDA and revenue.
The difference between EBITDA and net income is substantial.
That gap exists partly because TBLA carries significant financial costs.
This brings us to the biggest risk in the investment case.
TBLA's Biggest Problem: Debt
At the end of 2025:
Interest-bearing debt: approximately Rp17.90 trillion
Cash and equivalents: approximately Rp667.8 billion
Equity: approximately Rp9.25 trillion
Interest-bearing debt increased approximately 20.9% year over year, while cash declined by approximately 46.5%.
This deserves serious attention.
Using interest-bearing debt divided by equity:
Debt / Equity ≈ 17.90 / 9.25 = 1.94x
That means interest-bearing debt was almost twice shareholder equity.
If total liabilities are compared with equity:
21.27 / 9.25 ≈ 2.30x
This is a highly leveraged balance sheet.
Net Debt Is Another Key Warning Signal
Estimated net debt:
Rp17.90 trillion − Rp0.67 trillion = approximately Rp17.24 trillion
Against FY2025 EBITDA of approximately Rp3.70 trillion:
Net Debt / EBITDA ≈ 4.65x
That is a significant leverage level.
For a commodity company, this is especially important because EBITDA can decline when commodity prices or operating conditions deteriorate.
A company with low debt can survive a commodity downturn more easily.
A highly leveraged company has less room for error.
Interest Coverage
FY2025 interest expense was approximately Rp1.38 trillion according to financial-market reporting based on the company's FY2025 financial statements.
Using FY2025 EBITDA:
EBITDA / Interest Expense ≈ 2.7x
This indicates that operating earnings cover interest costs, but the cushion is not enormous.
If EBITDA were to fall sharply during a palm-oil or biodiesel downturn, interest coverage could deteriorate quickly.
This is why TBLA should be classified as a higher-risk value stock, rather than a conservative dividend stock.
1Q2026: Has the Growth Continued?
The first-quarter 2026 numbers provide an encouraging update.
According to TBLA's official consolidated financial statements:
1Q2026
Revenue:
Rp6.09 trillion
versus:
Rp5.60 trillion in 1Q2025
Revenue increased approximately:
8.7%
Gross profit increased to approximately:
Rp1.04 trillion
from:
Rp978.7 billion
Net profit attributable to the parent company reached approximately:
Rp275.5 billion
versus:
Rp274.4 billion
in 1Q2025.
The most important observation is that revenue continued to grow, but net income was almost flat year over year.
That suggests investors should be careful about extrapolating the strong 2025 earnings growth into 2026.
TBLA Valuation in 2026
At a reference market price of approximately Rp615 per share, TBLA's valuation appears inexpensive.
The company reported FY2025 EPS of approximately Rp150 per share.
Using:
Rp615 ÷ Rp150
produces an approximate trailing P/E ratio of:
4.1x
That is a low earnings multiple.
Book value per share is also significantly higher than the stock price.
Using FY2025 equity of approximately Rp9.25 trillion and roughly 6 billion shares, estimated book value per share is around:
Rp1,540 per share
At Rp615:
Price / Book ≈ 0.40x
This is potentially attractive for value investors.
But there is an important principle:
A low P/E ratio does not automatically mean a stock is undervalued.
Sometimes a low valuation multiple reflects genuine risks.
In TBLA's case, those risks include leverage, commodity prices, currency movements and emerging-market exposure.
Market data around August 2026 also show TBLA trading well below its 52-week high, reinforcing the market's cautious stance toward the stock.
What Could Make TBLA Stock Re-Rating Possible?
There are several potential catalysts.
1. Successful B50 Implementation
The largest potential catalyst is the continued expansion of Indonesia's biodiesel program.
The government officially launched B50 in July 2026.
If TBLA can increase FAME volumes without sacrificing margins, its earnings power could improve.
2. Higher Palm Oil Prices
TBLA's upstream and downstream exposure means stronger CPO prices can potentially benefit parts of the business.
However, this is not a simple positive relationship because higher CPO prices also increase raw-material costs for its processing activities.
Therefore:
Higher CPO prices are not automatically bullish for TBLA's net profit.
The impact depends on the company's ability to pass costs through to customers.
3. Debt Reduction
This may actually be more important than revenue growth.
If TBLA can use operating cash flow to reduce debt, the investment thesis could improve substantially.
Lower debt would mean:
lower interest expense,
stronger net profit,
better interest coverage,
lower financial risk,
greater resilience during commodity downturns.
A falling net-debt-to-EBITDA ratio would be an especially important signal for investors.
4. Higher Capacity Utilization
The company's biodiesel business could benefit from greater utilization of its production capacity under B50.
The company has indicated that it expects to fully utilize approximately 1 million kiloliters per year of production capacity under the higher biodiesel mandate.
Higher utilization can improve fixed-cost absorption and potentially support margins.
Major Risks for U.S. Investors
An American investor should consider risks that may not be obvious when looking only at the company's P/E ratio.
Currency Risk
TBLA reports its financial statements in Indonesian rupiah.
A U.S. investor ultimately evaluates returns in U.S. dollars.
For example:
If TBLA stock rises 10% in rupiah terms but the Indonesian rupiah falls 10% against the U.S. dollar, the dollar-based return could be substantially lower.
Currency movements can therefore materially affect an American investor's realized return.
Emerging-Market Risk
TBLA is listed in Indonesia.
Investors therefore face:
Indonesian regulatory changes,
local interest rates,
political risk,
foreign-investment restrictions,
liquidity differences,
currency risk,
accounting and disclosure differences,
taxation issues.
These risks deserve a higher valuation discount than a comparable U.S. company may receive.
Commodity Price Risk
Palm oil is a globally traded commodity.
Prices can be influenced by:
weather,
crop yields,
global inventories,
soybean and other vegetable-oil prices,
energy markets,
biofuel policies,
export restrictions,
geopolitical developments.
A favorable biodiesel policy does not eliminate commodity-cycle risk.
Sustainability and ESG Risk
Palm oil remains a controversial commodity in global markets because of concerns involving:
deforestation,
biodiversity,
peatland,
greenhouse-gas emissions,
labor practices,
land use.
For U.S. institutional investors and ESG-focused funds, these issues can affect the investment case.
Indonesia's Financial Services Authority (OJK) has incorporated sustainable-finance requirements and specifically recognizes sustainability certification frameworks for palm-oil activities, including ISPO, RSPO and ISCC.
OJK's sustainable-finance framework also requires Indonesian public companies to address sustainability reporting and related responsibilities.
Therefore, investors should monitor TBLA's sustainability disclosures alongside its financial statements.
Bull Case vs. Bear Case
| Bull Case | Bear Case |
|---|---|
| B50 increases biodiesel demand | High financial leverage |
| Revenue growth remains strong | Interest costs remain high |
| FAME volumes increase | CPO input prices rise |
| Capacity utilization improves | Commodity prices decline |
| Debt gradually falls | Cash balance remains weak |
| EPS grows faster than expected | Margins deteriorate |
| Low P/E attracts value investors | Low P/E reflects structural risk |
| PBV below 0.5x offers valuation support | Emerging-market discount persists |
My Financial Assessment of TBLA
From a fundamental perspective, TBLA is much more interesting today than the older 2025 article suggested.
The company's FY2025 performance demonstrated strong growth:
Revenue: +31.4%
Gross profit: +26.6%
Operating profit: +22.6%
Net income: +28.5%
EBITDA: +17.4%
The problem is that the balance sheet remains heavily leveraged.
The investment case therefore depends on whether future operating growth can outpace financial risk.
My interpretation is:
Valuation: Attractive
A P/E around 4x and price-to-book around 0.4x can be compelling for a value investor.
Growth: Positive
The biodiesel business provides a structural growth opportunity.
Profitability: Moderate
Net margin remains below 5%, leaving limited room for operational mistakes.
Balance Sheet: High Risk
Debt is the biggest weakness in the investment thesis.
Catalyst: Strong
B50 represents a meaningful policy-driven demand catalyst.
Risk Level: High
TBLA is not appropriate for investors looking for a low-volatility, highly predictable compounder.
What Should U.S. Investors Watch Next?
Rather than focusing only on the stock price, investors should monitor five numbers every quarter:
1. Revenue Growth
Is revenue continuing to grow?
2. EBITDA Margin
Is additional revenue generating meaningful operating profit?
3. Net Debt / EBITDA
Is leverage declining?
4. Interest Expense
Is financing becoming cheaper or more expensive?
5. Net Profit
Ultimately, revenue growth must translate into higher earnings per share.
A particularly attractive scenario would be:
Revenue ↑ + EBITDA ↑ + Net Debt ↓ + EPS ↑
That combination could provide the foundation for a meaningful valuation re-rating.
Conversely:
Revenue ↑ + Debt ↑ + Margin ↓
would be a warning sign that growth is being purchased with excessive financial leverage.
Is TBLA Stock a Buy for U.S. Investors?
TBLA is not a conventional U.S.-style dividend or defensive investment.
It is better viewed as a high-risk emerging-market value opportunity linked to palm oil, biodiesel and Indonesian energy policy.
At roughly 4x trailing earnings and below book value, the valuation is undeniably interesting.
The B50 program provides an additional structural catalyst, and the company's 2025 financial results demonstrate that biodiesel has already become a much larger component of the business.
However, the balance sheet prevents me from viewing TBLA as a low-risk bargain.
The approximately Rp17.9 trillion of interest-bearing debt compared with approximately Rp9.25 trillion of equity is the central issue investors must understand.
Bottom line:
TBLA may appeal to aggressive value investors who are comfortable with Indonesian equities, commodity cycles, currency risk and leverage.
For conservative U.S. investors, however, the low valuation alone is not enough to compensate for the financial risk.
The strongest long-term signal would be evidence that TBLA can use the B50-driven increase in biodiesel demand to grow earnings while simultaneously reducing leverage.
That would potentially transform TBLA from a cheap commodity stock into a more compelling emerging-market value story.
Final Investor Scorecard
| Category | Assessment |
|---|---|
| Valuation | ⭐⭐⭐⭐⭐ |
| Revenue Growth | ⭐⭐⭐⭐ |
| Earnings Growth | ⭐⭐⭐⭐ |
| Biodiesel Opportunity | ⭐⭐⭐⭐⭐ |
| Balance Sheet | ⭐⭐ |
| Profit Margin | ⭐⭐⭐ |
| Dividend Reliability | ⭐⭐⭐ |
| Commodity Risk | ⭐⭐ |
| Emerging-Market Risk | ⭐⭐ |
| Long-Term Potential | ⭐⭐⭐⭐ |
| Overall Risk | High |
Investment view: SPECULATIVE VALUE / HIGH RISK
This is not a recommendation to buy or sell TBLA. Investors should conduct independent due diligence and consider their risk tolerance, investment horizon, currency exposure and access to the Indonesian market.
Primary Sources and References
PT Tunas Baru Lampung Tbk — Official Financial Statements
TBLA Official Financial Statements
The company's investor-relations materials provide the primary source for its consolidated financial statements and quarterly reporting.
PT Tunas Baru Lampung Tbk — FY2025 Investor Newsletter
TBLA FY2025 Newsletter
This source contains FY2025 revenue, profit, EBITDA, debt, equity, cash, palm-oil production and biodiesel/FAME data.
PT Tunas Baru Lampung Tbk — 1Q2026 Financial Statements
TBLA 1Q2026 Financial Statements
The company's 1Q2026 filing reports revenue of Rp6.09 trillion and net income attributable to the parent of Rp275.47 billion.
Indonesia Ministry of Energy and Mineral Resources (ESDM) — B50 Program
Indonesia's B50 Biodiesel Program
ESDM provides primary government information regarding the implementation and economic objectives of Indonesia's B50 biodiesel policy.
Financial Services Authority of Indonesia (OJK) — Sustainable Finance
OJK Sustainable Finance Framework
OJK provides the regulatory and sustainable-finance framework relevant to Indonesian public companies and palm-oil activities.
U.S. Department of Agriculture — Indonesia Biofuels Annual Report
USDA Indonesia Biofuels Annual Report
USDA's Foreign Agricultural Service provides independent U.S. government analysis of Indonesia's biodiesel market and the country's transition toward higher blending mandates.
Investment Disclaimer
This article is provided for educational and informational purposes only. It is not personalized investment, tax or financial advice. TBLA is an Indonesian-listed stock and may involve substantial currency, liquidity, commodity, regulatory, political and emerging-market risks.
Past performance does not guarantee future results. U.S. investors should independently verify financial statements, brokerage access, transaction costs and applicable U.S. and Indonesian tax rules before investing in foreign securities.
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks
Join Facebook Group